Skip to main content
See the bias in every story
Published • loading... • Updated

Ebola Vaccine Trial Begins In DR Congo

The Tumaini trial will test Ervebo and other candidates to see whether they protect against the Bundibugyo strain, WHO said.

  • On Friday, the first participants were vaccinated in Bunia, DRC, in the Tumaini Ebola vaccine trial. WHO chief Tedros Adhanom Ghebreyesus said the trial aims to determine if vaccine candidates can effectively target the Bundibugyo virus.
  • The DRC's worst Ebola outbreak has surpassed 9,700 cases, with deaths exceeding 4,600. A primary challenge remains the absence of approved vaccines or treatments for the Bundibugyo species of Ebola driving this epidemic.
  • Researchers will initially test the Everbo vaccine, approved for the Zaire strain, for potential cross-protection against Bundibugyo. Future phases will incorporate two Bundibugyo-specific candidates: a ChAdOx1 vector vaccine from the University of Oxford and an mRNA jab from US-based Moderna.
  • The World Health Organization is supporting this DRC-led effort to evaluate the vaccines and provide critical data on safety and efficacy. Officials hope the trial framework will eventually help save lives during the ongoing health crisis.
  • Named Tumaini, which means 'hope' in Swahili, the trial framework allows researchers to test multiple vaccines simultaneously. This scientific approach aims to identify whether existing or new candidates can mitigate the threat posed by the Bundibugyo virus.
Insights by Ground AI

17 Articles

The HinduThe Hindu
+4 Reposted by 4 other sources
Lean Left

Ebola vaccine trial begins in DR Congo

Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo

·Chennai, India
Read Full Article
Lean Right

The first clinical trial of an Ebola vaccine in connection with the outbreak that has hit Congo-Kinshasa has…

·Stockholm, Sweden
Read Full Article
Lean Left

WHO chief Tedros Adhanom Ghebreyesus said on X: 'Science gives us hope. Today, in Bunia DRC, the first participants were vaccinated in a new Ebola vaccine trial called Tumaini, which means 'hope' in Swahili.'

·Paris, France
Read Full Article
Center

The epidemic has already left more than 4,600 people dead in the Democratic Republic of the Congo. The first clinical trial of an Ebola vaccine in the Democratic Republic of the Congo is...

·Brussels, Belgium
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 40% of the sources lean Right
40% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

News Agency of Nigeria broke the news on Friday, October 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal